alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
```

[Congressional Bills 114th Congress]
[From the U.S. Government Publishing Office]
[H.R. 1923 Introduced in House (IH)]

114th CONGRESS
  1st Session
                                H. R. 1923

To require the Administrator of the Environmental Protection Agency to 
 appoint a coordinator for issues relating to harmful algal blooms in 
                the Great Lakes, and for other purposes.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                             April 21, 2015

 Mr. Ryan of Ohio (for himself, Mr. Joyce, and Ms. Kaptur) introduced 
      the following bill; which was referred to the Committee on 
Transportation and Infrastructure, and in addition to the Committee on 
 Natural Resources, for a period to be subsequently determined by the 
  Speaker, in each case for consideration of such provisions as fall 
           within the jurisdiction of the committee concerned

_______________________________________________________________________

                                 A BILL

 
To require the Administrator of the Environmental Protection Agency to 
 appoint a coordinator for issues relating to harmful algal blooms in 
                the Great Lakes, and for other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. GREAT LAKES HARMFUL ALGAL BLOOM COORDINATOR.

    The Administrator of the Environmental Protection Agency, acting as 
chair of the Great Lakes Interagency Task Force, shall appoint a 
coordinator to work with appropriate Federal agencies and State, local, 
tribal, and foreign governments to address the issue of harmful algal 
blooms in the Great Lakes.
                                 <all>
```
# C_2021367EN.01000801.xml

| 13.9.2021 | EN | Official Journal of the European Union | C 367/8 |
| --- | --- | --- | --- |

13.9.2021

EN

Official Journal of the European Union

C 367/8

---

Prior notification of a concentration

(Case M.10108 – S&P Global/IHS Markit)

(Text with EEA relevance)

(2021/C 367/07)

1.

This notification concerns the following undertakings:

| — | S&P Global, Inc. (‘S&P’, United States), |
| --- | --- |

—

S&P Global, Inc. (‘S&P’, United States),

| — | IHS Markit (‘IHSM’, United Kingdom). |
| --- | --- |

—

IHS Markit (‘IHSM’, United Kingdom).

S&P acquires within the meaning of Article 3(1)(b) of the Merger Regulation control of the whole of IHSM.

The concentration is accomplished by way of purchase of shares.

2.

| — | S&P, a US company headquartered in New York, is a supplier of credit ratings, price assessments/benchmarks, financial indices, analytics, and data to the capital and commodity markets worldwide. |
| --- | --- |

—

S&P, a US company headquartered in New York, is a supplier of credit ratings, price assessments/benchmarks, financial indices, analytics, and data to the capital and commodity markets worldwide.

| — | IHSM, a Bermuda company headquartered in London, is an international provider of information (including financial indices, other financial and transportation related data and commodity prices assessments/benchmarks), analytics and solutions to customers in business, finance and government globally. |
| --- | --- |

—

IHSM, a Bermuda company headquartered in London, is an international provider of information (including financial indices, other financial and transportation related data and commodity prices assessments/benchmarks), analytics and solutions to customers in business, finance and government globally.

3.

On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved.

4.

Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified:

M.10108 – S&P Global/IHS Markit

Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below:

Email: COMP-MERGER-REGISTRY@ec.europa.eu

Fax +32 22964301

Postal address:

| European Commission |
| --- |
| Directorate-General for Competition |
| Merger Registry |
| 1049 Bruxelles/Brussel |
| BELGIQUE/BELGIË |

European Commission

Directorate-General for Competition

Merger Registry

1049 Bruxelles/Brussel

BELGIQUE/BELGIË

---

(1)  OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).

1

---
Exhibit 32.1



CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002



In connection with the Annual Report on Form 10-K, as amended, of NMT
Medical, Inc. (the Company) for the period ended December 31, 2003 as filed with the Securities and Exchange Commission on the date hereof (the Report), the undersigned, John E. Ahern, Chief Executive Officer of the Company,
hereby certifies, pursuant to 18 U.S.C. Section 1350, that:



(1) the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and



(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.



|                     |  |                                                    
|-------------------- |  | ---------------------------------------------------
|Date: April 28, 2004 |  | /S/ JOHN E. AHERN                                  
|                     |  | John E. Ahern President and Chief Executive Officer
<TABLE> <S> <C>

<PAGE>
 
<ARTICLE> 5
<CIK> 0001018739
<NAME> PECAN GROVE GOLF CLUB, INC.
       
<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                          SEP-30-1997
<PERIOD-START>                             OCT-01-1996
<PERIOD-END>                               SEP-30-1997
<CASH>                                          13,340
<SECURITIES>                                         0
<RECEIVABLES>                                  295,740
<ALLOWANCES>                                    25,286
<INVENTORY>                                     74,165
<CURRENT-ASSETS>                               343,498
<PP&E>                                       9,445,986
<DEPRECIATION>                               1,528,272
<TOTAL-ASSETS>                               3,831,766
<CURRENT-LIABILITIES>                          385,857
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                         1,000
<OTHER-SE>                                   3,249,751
<TOTAL-LIABILITY-AND-EQUITY>                 3,831,766
<SALES>                                        998,805
<TOTAL-REVENUES>                             3,823,307
<CGS>                                          442,175
<TOTAL-COSTS>                                3,390,261
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                39,367
<INTEREST-EXPENSE>                              21,532
<INCOME-PRETAX>                                411,514
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                            411,514
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   411,514
<EPS-PRIMARY>                                        0
<EPS-DILUTED>                                        0
        

</TABLE>
**EXHIBIT 13.2**
Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
In connection with the Annual Report on Form 20-F of Radcom Ltd. (the“Company”) for the period ending December 31, 2003 (the “Report”), I, DavidZigdon, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C.Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of2002, that:
1. the Report fully complies with the requirements of Section 13(a) or 15(d) ofthe Securities Exchange Act of 1934; and
2. the information contained in the Report fairly presents, in all materialrespects, the financial condition and results of operations of the Company.
Date: May 5, 2004 */s/ David Zigdon*David ZigdonChief Financial Officer
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS RESTATED FINANCIAL DATA SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION
EXTRACTED FROM THE FINANCIAL STATEMENTS OF BLOUNT INTERNATIONAL, INC. FOR THE
PERIOD ENDED DECEMBER 31, 1996, AS SET FORTH IN ITS FORM 10-K FOR SUCH PERIOD
AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<RESTATED>
<MULTIPLIER> 1000000

<S>                             <C>
<PERIOD-TYPE>                   10-MOS
<FISCAL-YEAR-END>                          DEC-31-1996
<PERIOD-START>                              MAR-1-1996
<PERIOD-END>                               DEC-31-1996
<CASH>                                              59
<SECURITIES>                                         0
<RECEIVABLES>                                      119
<ALLOWANCES>                                         3
<INVENTORY>                                         82
<CURRENT-ASSETS>                                   281
<PP&E>                                             302
<DEPRECIATION>                                     170
<TOTAL-ASSETS>                                     534
<CURRENT-LIABILITIES>                              115
<BONDS>                                             85
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                             0
<OTHER-SE>                                         291
<TOTAL-LIABILITY-AND-EQUITY>                       534
<SALES>                                            527
<TOTAL-REVENUES>                                   527
<CGS>                                              347
<TOTAL-COSTS>                                      347
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   8
<INCOME-PRETAX>                                     70
<INCOME-TAX>                                        26
<INCOME-CONTINUING>                                 44
<DISCONTINUED>                                       1
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                        45
<EPS-BASIC>                                     0.59<F1>
<EPS-DILUTED>                                     0.58<F1>
<FN>
<F1> RESTATEMENT REFLECTED HEREIN IS THE RESULT OF THE PRORATION AND STOCK
ELECTION PROCEDURES RELATED TO THE AUGUST 19, 1999 MERGER AS DESCRIBED IN
NOTE 2 OF NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS INCLUDED IN
BLOUNT INTERNATIONAL, INC.'S FORM 10-Q FOR THE QUARTERLY PERIOD ENDED
SEPTEMBER 30, 1999.
</FN>


</TABLE>
Skip to main content

Privacy Policy•Site map

# Margaret M. Sweeney

Judge Sweeney was appointed a Judge of the United States Court of Federal Claims by President George W. Bush on October 24, 2005, and entered duty on December 14, 2005. She served as Chief Judge from July 12, 2018 - October 18, 2020. She graduated from Notre Dame of Maryland, receiving a B.A. degree in history in 1977, and from Delaware Law School, receiving a J.D. degree in 1981. Judge Sweeney formerly was a Special Master for the United States Court of Federal Claims (2003 - 2005). Prior to that appointment, Judge Sweeney served as an Attorney Advisor for the United States Department of Justice Office of Intelligence Policy and Review (1999 - 2003). In that position, she prepared applications and motions on behalf of various United States intelligence agencies for presentation to the Foreign Intelligence Surveillance Court. Prior to joining the Office of Intelligence Policy and Review, Judge Sweeney served as a Trial Attorney in the General Litigation Section of the Environment and Natural Resources Division of the United States Department of Justice (1987 - 1999). From 1985 to 1987, she served as law clerk to the Honorable Loren A. Smith, Chief Judge of the United States Court of Federal Claims. Judge Sweeney was a litigation associate from 1983 to 1985, with the firm of Fedorko, Gilbert, & Lanctot, Morrisville, Pennsylvania, handling civil and criminal cases, including commercial litigation, personal injury, domestic relations, real property and estates. Judge Sweeney also served as a Delaware Family Court Master presiding over cases involving domestic relations matters (1981 - 1983). Judge Sweeney is a member of the bars of the Supreme Court of Pennsylvania and the District of Columbia Court of Appeals. In 1999, she served as President of the United States Court of Federal Claims Bar Association. Judge Sweeney and her family reside in the Washington metropolitan area.

Howard T. Markey National Courts Building • 717 Madison Place, NW, Washington, DC 20439 • 202-357-6400
Listen

# Steven Horsford

## U.S. Representative and CSSBMB Commissioner

Commissioner Horsford worked to bring the first of its kind workforce development program for youth and young adults to North Las Vegas. He helped to launch a food recovery program with Three Square and major employers like MGM Resorts to address food insecurity among needy children, families and seniors. He brings a principled focus on job creation, community development and skills development to Congress. He understands the challenges many families in Nevada's Fourth face each and every day. He will fight for responsible gun control and background checks. He will work tirelessly to end the school to prison pipeline and provide the safety net children and families need to succeed. He is committed to restoring public faith in American institutions.

-  Our Mission 
-  Commissioners 
-  Offices and Staff 
-  Careers 
-  Acquisition Opportunities 
-  Rankin Memorial Library 
-  FAQs
# C_2021215EN.01001001.xml

| 7.6.2021 | EN | Official Journal of the European Union | C 215/10 |
| --- | --- | --- | --- |

7.6.2021

EN

Official Journal of the European Union

C 215/10

---

Prior notification of a concentration

(Case M.10165 — Astrazeneca/Alexion Pharmaceuticals)

(Text with EEA relevance)

(2021/C 215/09)

1.

This notification concerns the following undertakings:

| — | AstraZeneca PLC (‘AstraZeneca’, UK); and |
| --- | --- |

—

AstraZeneca PLC (‘AstraZeneca’, UK); and

| — | Alexion Pharmaceuticals Inc. (‘Alexion’, USA). |
| --- | --- |

—

Alexion Pharmaceuticals Inc. (‘Alexion’, USA).

AstraZeneca acquires, within the meaning of Article 3(1)(b) of the Merger Regulation, sole control of the whole of Alexion. The concentration is accomplished by way of purchase of shares.

2.

| — | for AstraZeneca: global pharmaceutical company engaged in the development and commercialisation of medicines in following core therapy areas: (i) oncology; (ii) cardiovascular, renal & metabolism; and (iii) respiratory & immunology; |
| --- | --- |

—

for AstraZeneca: global pharmaceutical company engaged in the development and commercialisation of medicines in following core therapy areas: (i) oncology; (ii) cardiovascular, renal & metabolism; and (iii) respiratory & immunology;

| — | for Alexion: US biopharmaceutical company focusing on rare and ultra-rare diseases for which there is high unmet medical need. |
| --- | --- |

—

for Alexion: US biopharmaceutical company focusing on rare and ultra-rare diseases for which there is high unmet medical need.

3.

On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved.

4.

Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified:

M.10165 — Astrazeneca/Alexion Pharmaceuticals

Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below:

Email: COMP-MERGER-REGISTRY@ec.europa.eu

Fax +32 22964301

Postal address:

| European Commission |
| --- |
| Directorate-General for Competition |
| Merger Registry |
| 1049 Bruxelles/Brussel |
| BELGIQUE/BELGIË |

European Commission

Directorate-General for Competition

Merger Registry

1049 Bruxelles/Brussel

BELGIQUE/BELGIË

---

(1)  OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).

1

---
REVISED 02/2022 1

United States Court

 of Federal Claims

ATTORNEY COMPLAINT FILING INSTUCTIONS

Before filing a complaint/petition electronically, please note the following:

1. Include as attachments, any additional documents you wish to file with

your pleading (e.g., civil cover sheet, disclosure statement, exhibits, etc.).

2. For voluminous attachments to complaints/petitions, see paragraph 9 of

Appendix E/paragraph 9 of Supplement to Appendix B.

3. Do not use digital signatures.

4. Once you have paid your filing fee, you must complete the transaction.

DO NOT hit the back button or you will incur a double charge. If a

correction to your filing is necessary, wait until your case is opened and

then contact the Clerk’s Office for assistance during business hours at

202-357-6406.

5. Please note that your pleading has not been filed until you reach the

screen that states “The following transaction was entered by [your name]

on xx/xx/xxxx.”

6. If submitted on a Saturday, Sunday, or legal holiday as defined by RCFC

6, your pleading will be deemed filed on the next day that is not a

Saturday, Sunday or legal holiday. Otherwise, your complaint/petition

will be deemed filed on the date submitted in CM/ECF.

7. The court will assign a case number and a judge/special master during

Clerk’s Office business hour as defined in RCFC 77.1. You will receive

a Notice of Electronic Filing once your complaint/petition has been

processed.
REVISED 02/2022 2

To file a complaint/petition electronically, please follow the 

instructions below.

1. Login to your PACER account.

2. Select Civil.
REVISED 02/2022 3

3. Select Attorney Complaint/Petition.

4. (1) Select the appropriate event; and (2) select Next.
REVISED 02/2022 4

5. (1) Input Case No. 22-10000; (2) select Find This Case; and (3)

select Next.

6. (1) Select Browse and locate your document; (2) select your document and

Open ; and (3) select Next. PLEASE NOTE: any additional documents you

wish to submit with your initial pleading MUST be included as attachments.

Those documents are to be attached in the same manner and given either a

Category from the dropdown menu OR a Description of your choice that

you will manually enter. Additionally, please confirm that you are

attaching the correct documents prior to selecting Next.
REVISED 02/2022 5

7. Select Next. PLEASE NOTE: there is a $53.00 chargeback fee for refunds

of duplicate or erroneously paid filing fees.

8. Login to your PACER account to begin the payment process.
REVISED 02/2022 6

9. (1) Select your payment method and input your information; and (2) select

Next.

10.(1) Input the Court Specific information; (2) input the Email Receipt address

(3) check the Authorization box; and (4) select Submit.
REVISED 02/2022 7

11. Select Next.

12. Select Next.
REVISED 02/2022 8

13. Select Next.

14. You have successfully filed your complaint/petition.
Listen

# Racial Disparities in Maternal Health

September 15, 2021

This report examines the federal role in addressing racial disparities in maternal health, including negative pregnancy-related health outcomes and pregnancy-related deaths of women in the United States. As attention of these disparities increases, so does the focus on disparities such as, Black women in the U.S. are three to four times more likely to die from pregnancy-related complications than white women in the U.S., and Native American women are more than two times more likely to die from pregnancy-related complications than white women in the U.S. These disparities have become more severe over the last thirty years. 

Report

Report

Press Release

Briefing November 13, 2020

-  All Reports 
-  Annual Statutory Enforcement 
-  Briefing Reports 
-  Advisory Committees Reports 
-  Budget and Performance 
-  FOIA Reports 
-  Data Inventory Program 
-  Civil Rights Complaints 
-  Historical Publications 
-  Archives
EXHIBIT 32.1

# CERTIFICATION PURSUANT
TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO

SECTION 906 OF THE
SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly
Report on Form 10-Q of IDX Systems Corporation (the Company) for the period
ended September 30, 2004 as filed with the Securities and Exchange Commission on the date
hereof (the Report), the undersigned, James H. Crook, Jr., Chief Executive
Officer of the Company, and John A. Kane, Chief Financial Officer of the Company, each
hereby certifies, pursuant to 18 U.S.C. Section 1350, that:

|(1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the
          Securities Exchange Act of 1934; and
|--- | -------------------------------------------------------------------------------------------------------------------------------

|(2) | The information contained in the Report fairly presents, in all material
          respects, the financial condition and results of operations of the Company.
|--- | --------------------------------------------------------------------------------------------------------------------------------------------------------------

|                          |                                                                                                                                                                       
|------------------------- | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------
|Dated:   November 2, 2004 | /s/    JAMES H. CROOK, JR.
________________________________________________
James H. Crook, Jr.
Chief Executive Officer                                               
|Dated:   November 2, 2004 | /s/    JOHN A. KANE
_______________________________________________
John A. Kane
Sr. Vice President, Finance and Administration,
Chief Financial Officer and Treasurer
# C_2021132EN.01000101.xml

| 15.4.2021 | EN | Official Journal of the European Union | C 132/1 |
| --- | --- | --- | --- |

15.4.2021

EN

Official Journal of the European Union

C 132/1

---

Non-opposition to a notified concentration

(Case M.10159 — Infosys/Daimler (Certain Assets and Personnel))

(Text with EEA relevance)

(2021/C 132/01)

On 8 April 2021, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

| — | in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes, |
| --- | --- |

—

in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

| — | in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32021M10159. EUR-Lex is the online access to European law. |
| --- | --- |

—

in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32021M10159. EUR-Lex is the online access to European law.

---

(1)  OJ L 24, 29.1.2004, p. 1.

---